Skip to main content

Table 2 Characteristics of patients with muscular dystrophy II (MD2) at follow-up

From: Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study

  Presence of Late Gadolinium Enhancement
All (n = 22) No (n = 17) Yes (n = 5)
Age (years) 58 ± 9 57 ± 9 61 ± 10
Male sex, n (%) 6 (27.3) 4 2
Heart rate (beats per minute) 69 ± 9 68 ± 9 72 ± 11
Systolic BP (mmHg) 130 ± 16 127 ± 16 139 ± 16
Diastolic BP (mmHg) 75 ± 10 73 ± 10 81 ± 9
Arterial hypertension, n (%) 7 (31.8) 4 3
Hyperlipidemia, n (%) 16 (72.7) 13 3
Diabetes mellitus, n (%) 3 (13.6) 3
Smoking, n (%) 2 (9.1) 1 1
Cardiac symptoms
 Asymptomatic, n (%) 16 (72.7) 11 2
 Palpitations, n (%) 6 (27.3) 4 2
 Chest pain, n (%) 1(4.5) 1 0
 Fatigue, n (%) 5 (22.7) 4 1
  1. Data are shown as mean values ± standard deviation (SD) according to the AHA-segment model. BP blood pressure